All News

A letter from Group Editorial Director, Megan L'Heureux, highlighting COVID-19 research, the announcement of Cannabis Science and Technology®'s partnership with Havas ECS, and the launch of our sister publication, Cannabis Patient Care™.

The Dental College of Georgia (DCG) and the Medical College of Georgia, recently performed a study which produced results showing that cannabidiol (CBD), a non-psychoactive cannabinoid found in cannabis, reduces damage in the lungs spurred by cytokine storms caused by coronavirus (COVID-19).

The U.S. Food and Drug Administration (FDA) recently released a draft guidance on developing cannabis-based drugs. These guidelines come weeks after the White House announced it had completed reviewing the draft guidance.